Animal Gastroesophageal Reflux Disease - Global Strategic Business Report

The global market for Animal Gastroesophageal Reflux Disease was estimated at US$3.2 Billion in 2024 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Animal Gastroesophageal Reflux Disease market.

Global Animal Gastroesophageal Reflux Disease Market - Key Trends & Drivers Summarized

Why Is Gastroesophageal Reflux Disease Becoming a Growing Concern in Animals?

The increasing prevalence of gastroesophageal reflux disease (GERD) in companion animals and livestock is becoming a significant concern among veterinarians and pet owners alike. Changes in dietary habits, rising obesity rates in pets, and the growing trend of humanizing pet diets have led to an increase in acid reflux cases in animals, particularly among dogs, cats, and horses. GERD in animals often results from the weakening of the lower esophageal sphincter, leading to acid regurgitation, discomfort, and long-term esophageal damage if left untreated. With the growing awareness about pet health and wellness, there is a surge in demand for effective diagnostic and therapeutic solutions to manage GERD symptoms. Advances in veterinary diagnostics, such as endoscopy and imaging techniques, are enabling early detection and improved treatment outcomes. Additionally, pet owners are increasingly seeking non-invasive and long-term management solutions, further driving the market for specialized medications, dietary supplements, and lifestyle modifications.

How Are Technological Advancements Influencing GERD Diagnosis and Treatment?

The rapid advancements in veterinary healthcare technology are revolutionizing the diagnosis and treatment of gastroesophageal reflux disease in animals. Modern diagnostic tools, including pH monitoring systems, radiography, and esophageal manometry, are enhancing veterinarians` ability to accurately diagnose GERD and develop personalized treatment plans. The growing adoption of minimally invasive procedures such as laparoscopic fundoplication in companion animals is improving treatment outcomes and reducing recovery times. Furthermore, the development of advanced pharmaceuticals, including proton pump inhibitors (PPIs), H2 receptor antagonists, and prokinetic agents, is providing more effective and targeted relief for GERD symptoms. Nutritional advancements, such as specialized diets formulated to minimize acid production and optimize digestive health, are also playing a crucial role in long-term disease management. These technological advancements are making GERD treatment more accessible and efficient, catering to the needs of both pet owners and commercial livestock producers.

What Challenges and Opportunities Exist in the Animal GERD Market?

Despite the promising growth prospects, the animal GERD market faces several challenges, including limited awareness about the condition, high treatment costs, and the lack of standardized treatment protocols across veterinary practices. Many pet owners and livestock farmers are unaware of the symptoms and long-term implications of GERD, leading to underdiagnosis and delayed treatment interventions. Additionally, the costs associated with advanced diagnostic procedures and long-term pharmaceutical treatments can be prohibitive for some pet owners, limiting market penetration. However, these challenges present significant opportunities for market growth, particularly through educational initiatives aimed at raising awareness about GERD symptoms and preventive measures. The growing emphasis on holistic pet wellness and preventive healthcare is creating demand for probiotic supplements, natural digestive aids, and functional foods that support gastrointestinal health. Furthermore, strategic collaborations between veterinary pharmaceutical companies and pet food manufacturers are fostering the development of integrated treatment solutions that combine medical therapy with nutritional support.

What Are the Key Factors Driving Growth in the Animal GERD Market?

The growth in the Animal Gastroesophageal Reflux Disease (GERD) market is driven by several factors, including the rising pet ownership rates, increased spending on veterinary healthcare, and the growing emphasis on companion animal wellness. The shift in consumer preferences towards premium pet healthcare services and preventive care is fueling demand for advanced treatment options for digestive disorders such as GERD. Additionally, the expansion of veterinary clinics and pet hospitals, particularly in emerging markets, is improving access to diagnostic and therapeutic solutions. The increasing incidence of GERD in performance animals, such as racehorses and working dogs, is also contributing to market growth, as owners seek specialized treatments to maintain optimal health and performance. With the continued advancements in veterinary pharmaceuticals, diagnostic tools, and nutrition science, the animal GERD market is poised for sustained growth, offering lucrative opportunities for industry stakeholders across the veterinary healthcare spectrum.

Report Scope

The report analyzes the Animal Gastroesophageal Reflux Disease market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Treatment Type, Diagnostics Type, Other Types); Animal Type (Companion Animals, Livestock Animals); Mode (OTC Mode, Prescription Mode); Distribution Channel (Online Distribution Channel, Veterinary Hospitals and Clinics, Retail Pharmacies)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Treatment Type segment, which is expected to reach US$2.7 Billion by 2030 with a CAGR of a 7.6%. The Diagnostics Type segment is also set to grow at 5.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $880.2 Million in 2024, and China, forecasted to grow at an impressive 10.7% CAGR to reach $996.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Animal Gastroesophageal Reflux Disease Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Animal Gastroesophageal Reflux Disease Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Animal Gastroesophageal Reflux Disease Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Annamaet Petfoods, Inc., Blue Buffalo Co., Ltd., Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

• Annamaet Petfoods, Inc.
• Blue Buffalo Co., Ltd.
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals PLC
• Elanco Animal Health, Inc.
• Heska Corporation
• Hill`s Pet Nutrition, Inc.
• Merck & Co., Inc.
• Phathom Pharmaceuticals, Inc.
• Sebela Pharmaceuticals Inc.
• Vetoquinol S.A.
• Zoetis, Inc.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry